| JTS2400107 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| JTS2400109 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| JTS2400106 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| JTS2400110 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| JTS2400105 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| JTS2400104 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| JTS2400108 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| CXSB2300105 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2023-10-11 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
| CXSL2000373 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-12-23 | 海门晟斯生物制药有限公司 | Jiangsu Shengsi Biopharmaceutical Co Ltd | In Review | 2020-12-22 | view |
| CXSB2300106 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2023-10-11 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
| CXSL2000372 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-12-23 | 海门晟斯生物制药有限公司 | Jiangsu Shengsi Biopharmaceutical Co Ltd | In Review | 2020-12-22 | view |
| JYSB1900352 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-01-01 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | In Review | 2019-12-31 | view |
| JYSB2400182 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-08-14 | | | | | view |
| JYSB0800074 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2008-06-28 | | Bayer Healthcare LLC | Certificate Issued | 2009-07-31 | view |
| JXSL1500015 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-04-17 | 精鼎医药研究开发（上海）有限公司 | Parexel China Co Ltd | Certificate Issued | 2017-12-06 | view |
| JYSB2000597 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-12-16 | | | Certificate Issued | 2021-03-02 | view |
| JXSL1400012 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2014-03-10 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2015-12-22 | view |
| JYSB2000401 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | | Filed | 2020-09-01 | view |
| JYSB1800178 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-08-17 | | | Filed | 2018-08-23 | view |
| JXSS1000007 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2010-09-15 | | | Certificate Issued | 2012-08-28 | view |
